![]() |
Volumn 76, Issue 2, 2010, Pages 337-341
|
Survival Following Radiation and Androgen Suppression Therapy for Prostate Cancer in Healthy Older Men: Implications for Screening Recommendations
|
Author keywords
Androgen suppression therapy; Comorbidity; Elderly; Prostate cancer; Radiation; Screening
|
Indexed keywords
ANDROGEN SUPPRESSION;
COMORBIDITY;
HAZARD RATIO;
LOCALIZED PROSTATE CANCER;
MULTIVARIABLE ANALYSIS;
PROSTATE CANCERS;
RADIATION SCREENING;
TASK FORCE;
EPIDEMIOLOGY;
PESTICIDE EFFECTS;
RADIOTHERAPY;
FLUTAMIDE;
GONADORELIN AGONIST;
ADULT;
AGED;
ANDROGEN DEPRIVATION THERAPY;
ARTICLE;
CANCER HORMONE THERAPY;
CANCER MORTALITY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SCREENING;
CANCER SURVIVAL;
CLINICAL EFFECTIVENESS;
CLINICAL EVALUATION;
COHORT ANALYSIS;
COMORBIDITY;
GROUPS BY AGE;
HIGH RISK PATIENT;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTIMODALITY CANCER THERAPY;
PRIORITY JOURNAL;
PROSTATE CANCER;
RADIATION DOSE;
TREATMENT DURATION;
TREATMENT OUTCOME;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ANDROGEN ANTAGONISTS;
COMBINED MODALITY THERAPY;
HEALTH STATUS;
HUMANS;
LIFE EXPECTANCY;
MALE;
MASSACHUSETTS;
MIDDLE AGED;
PRACTICE GUIDELINES AS TOPIC;
PROPORTIONAL HAZARDS MODELS;
PROSTATIC NEOPLASMS;
RADIOTHERAPY;
RISK ASSESSMENT;
|
EID: 73649114924
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijrobp.2009.01.045 Document Type: Article |
Times cited : (14)
|
References (12)
|